06/09/2026
Hines program joins VA trials at sites in Houston, New York, and San Francisco, creating the most geographically distributed clinical evidence-generation program for psꪗchꫀdeꪶic therapy in federal healthcare history.
The scientific basis for ps𝒾𝓁𝑜cy𝒷𝒾𝓃 in PTSD treatment is now substantial. Phase 2 trial data from MAPS (Multidisciplinary Association for Psꪗchꫀdeꪶic Studies) and Compass Pathways have consistently shown clinically significant reductions in PTSD symptom severity following ps𝒾𝓁𝑜cy𝒷𝒾𝓃-assisted therapy sessions, with effect sizes that exceed those of the best currently available pharmacological interventions (SSRIs and SNRIs).
Check out the full article here:
https://www.medicaldaily.com/chicagos-va-hospital-just-enrolled-its-first-veterans-psilocybin-assisted-therapy-program-475537